Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Reblin

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Acta Hepato-Gastroenterologica|June 1, 1975
Determination of the specific blood flow of the liver by inhalation of radioactive rare gasesI Schmitz-Feuerhake, H Huchzermeyer, T Reblin
European Journal of Clinical Investigation|October 1, 1977
Determination of splenic blood flow by inhalation of radioactive rare gasesH Huchzermeyer, I Schmitz-Feuerhake, T Reblin
Mycoses|July 1, 1994
Disseminated cryptococcosis in a patient with AIDST Reblin, A Meyer, H Albrecht, et al.
Atherosclerosis|July 31, 1999
Quantification of lipoprotein(a) and apolipoprotein(a) in plasma and lipoprotein fractions in the hypertriglyceridemic stateT Reblin, K R Hahn, F Bethge, et al.
European Heart Journal|August 1, 1990
Lipoprotein(a) in the arterial wallU Beisiegel, A Niendorf, K Wolf, et al.
Atherosclerosis|March 1, 1995
Extraction of lipoprotein(a), apo B, and apo E from fresh human arterial wall and atherosclerotic plaquesT Reblin, N Meyer, C Labeur, et al.
International Journal of Clinical Practice|August 31, 2006
Rosiglitazone is effective and well-tolerated in a range of therapeutic regimens during daily practice in patients with type 2 diabetesC Rosak, E Standl, T Reblin, et al.
Atherosclerosis|June 11, 1992
Correlation of apolipoprotein(a) isoproteins with Lp(a) density and distribution in fasting plasmaT Reblin, D J Rader, U Beisiegel, et al.
International Journal of Clinical Practice|September 24, 2005
Rosiglitazone plus metformin is effective and well tolerated in clinical practice: results from large observational studies in people with type 2 diabetesC Rosak, R Petzoldt, R Wolf, et al.
Coronary Artery Disease|April 1, 1995
Differences in lipoprotein (a) and apolipoprotein (a) levels in men and women with advanced coronary atherosclerosisG M Stiel, T Reblin, M Bührlen, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Acta Hepato-Gastroenterologica|June 1, 1975
Determination of the specific blood flow of the liver by inhalation of radioactive rare gasesI Schmitz-Feuerhake, H Huchzermeyer, T Reblin
European Journal of Clinical Investigation|October 1, 1977
Determination of splenic blood flow by inhalation of radioactive rare gasesH Huchzermeyer, I Schmitz-Feuerhake, T Reblin
Mycoses|July 1, 1994
Disseminated cryptococcosis in a patient with AIDST Reblin, A Meyer, H Albrecht, et al.
Atherosclerosis|July 31, 1999
Quantification of lipoprotein(a) and apolipoprotein(a) in plasma and lipoprotein fractions in the hypertriglyceridemic stateT Reblin, K R Hahn, F Bethge, et al.
European Heart Journal|August 1, 1990
Lipoprotein(a) in the arterial wallU Beisiegel, A Niendorf, K Wolf, et al.
Atherosclerosis|March 1, 1995
Extraction of lipoprotein(a), apo B, and apo E from fresh human arterial wall and atherosclerotic plaquesT Reblin, N Meyer, C Labeur, et al.
International Journal of Clinical Practice|August 31, 2006
Rosiglitazone is effective and well-tolerated in a range of therapeutic regimens during daily practice in patients with type 2 diabetesC Rosak, E Standl, T Reblin, et al.
Atherosclerosis|June 11, 1992
Correlation of apolipoprotein(a) isoproteins with Lp(a) density and distribution in fasting plasmaT Reblin, D J Rader, U Beisiegel, et al.
International Journal of Clinical Practice|September 24, 2005
Rosiglitazone plus metformin is effective and well tolerated in clinical practice: results from large observational studies in people with type 2 diabetesC Rosak, R Petzoldt, R Wolf, et al.
Coronary Artery Disease|April 1, 1995
Differences in lipoprotein (a) and apolipoprotein (a) levels in men and women with advanced coronary atherosclerosisG M Stiel, T Reblin, M Bührlen, et al.
Pageof 2